Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
C

Captor Therapeutics SA
WSE:CTX

Watchlist Manager
Captor Therapeutics SA
WSE:CTX
Watchlist
Price: 53.7 PLN -2.19% Market Closed
Market Cap: zł341m
Write Note Create Alert

Intrinsic Value

Is CTX undervalued or overvalued?

See the intrinsic value estimate for Captor Therapeutics SA and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

CTX Intrinsic Value
LOCKED
Unlock
Today vs. history

CTX looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with CTX’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor CTX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price zł53.7
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CTX

Fundamental Analysis

What Captor Therapeutics Does

Captor Therapeutics is a drug-discovery company that designs medicines based on targeted protein degradation. Instead of trying only to block a disease-causing protein, its approach aims to tag that protein for removal inside the cell. The company mainly works on early-stage research programs for hard-to-treat diseases, especially in oncology and other areas where new treatment options are needed.

Headquarters
Poland PL
Employees
98
IPO date
Apr 19, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Captor Therapeutics SA

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Continue CTX Research

Summary
CTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CTX stock valuation using valuation multiples.
Wall St Estimates
CTX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Captor Therapeutics SA listings:
F • EUR
60Q
Discover More
What is the Intrinsic Value of one CTX stock?

The intrinsic value for Captor Therapeutics SA (CTX) under the Base Case is hidden PLN.

Is CTX stock undervalued or overvalued?

Compared with the current market price of 53.7 PLN, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.